How do cryptogenic and symptomatic infantile spasms differ? Review of biochemical studies in Finnish patients

Area of Science:

• Neuroscience
• Biochemistry
• Pediatrics

Background:

• Infantile spasms (IS) are a severe epilepsy syndrome in infants.
• Distinguishing between cryptogenic and symptomatic IS is crucial for prognosis and treatment.
• Previous research suggests potential biochemical differences between IS subtypes.

Purpose of the Study:

• To investigate and compare the biochemical profiles of infants with cryptogenic infantile spasms versus those with symptomatic infantile spasms.
• To identify specific biomarkers that differentiate these two groups.
• To explore the potential pathophysiological implications of observed biochemical differences.

Main Methods:

• Analysis of cerebrospinal fluid (CSF) and serum samples from infants diagnosed with infantile spasms.
• Measurement of corticotropin levels and response to vasopressin.
• Quantification of serum progesterone and dehydroepiandrosterone: androstenedione ratio.
• Assessment of CSF gamma-aminobutyric acid and nerve growth factor concentrations.

Main Results:

• Infants with cryptogenic IS exhibited higher CSF corticotropin levels compared to symptomatic IS.
• Differences in corticotropin release following vasopressin administration were observed.
• Elevated serum progesterone and a higher dehydroepiandrosterone: androstenedione ratio (during therapy) were noted in cryptogenic IS.
• Higher CSF gamma-aminobutyric acid and nerve growth factor concentrations were found in cryptogenic IS.

Conclusions:

• Significant biochemical distinctions exist between cryptogenic and symptomatic infantile spasms.
• These differences, particularly in neurochemical markers, may underlie the distinct pathophysiological mechanisms of IS subtypes.
• Further research is needed to determine if these biochemical variations are specific or secondary to early brain damage.